ClinicalTrials.Veeva

Menu

Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy (GOAL-AI)

Duke University logo

Duke University

Status

Begins enrollment in 3 months

Conditions

Breast Cancer, Hormone Receptor Positive, Aromatase Inhibitor-Associated Arthralgia

Treatments

Behavioral: CST-AI
Behavioral: GOAL-AI

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07232056
Pro00118528

Details and patient eligibility

About

Older women (≥65 years) with HR+ non-metastatic breast cancer experience high symptom burden and reduced quality of life during aromatase inhibitor (AI) therapy. This hierarchical 2×2 factorial randomized controlled trial will test two interventions: (1) a clinic-level geriatric oncology assessment and support program (GOAL-AI) and (2) a patient-level CBT-based coping skills training (CST-AI). The study aims to improve pain, symptom burden, and health-related quality of life compared to enhanced usual care.

Enrollment

452 estimated patients

Sex

Female

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female, age ≥65 years
  • HR+ non-metastatic breast cancer
  • Within 12 months of starting AI therapy
  • English-speaking
  • Able to provide consent

Exclusion criteria

  • Age <65 years
  • Metastatic cancer
  • Cognitive impairment preventing consent
  • Receiving care at multiple participating sites

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

452 participants in 4 patient groups

GOAL-AI + CST-AI
Experimental group
Description:
Combination of clinic-level geriatric assessment and CBT-based coping skills training.
Treatment:
Behavioral: GOAL-AI
Behavioral: CST-AI
GOAL-AI alone
Experimental group
Description:
Clinic-level geriatric assessment and support only.
Treatment:
Behavioral: GOAL-AI
CST-AI alone
Experimental group
Description:
CBT-based coping skills training only.
Treatment:
Behavioral: CST-AI
Enhanced Usual Care
No Intervention group
Description:
Standard care with educational materials.

Trial contacts and locations

0

Loading...

Central trial contact

Michael W Willis, BA; Smrithi Divakaran, MBBS, MSPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems